Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.58 Analyst target: $10.06 Upside: 181.01%
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
See the full interactive analysis & chart →Informational only — not investment advice.